PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 1992Neurology120 citations

Hypotension‐induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure

View Full Paper
HKHoracio KaufmannEOE. OribeMMMarc A. Miller

Structured PICO

Does upright tilt-induced vasopressin release differentiate between pure autonomic failure and multiple system atrophy?

P
Population
Patients with pure autonomic failure (PAF), patients with multiple system atrophy with autonomic failure (MSA), and 14 normal subjects (9 of whom developed acute hypotension due to vasovagal syncope).
I
Intervention
Upright tilt testing
C
Comparator
Comparison between PAF, MSA, and normal subjects
O
Outcome
Circulating levels of vasopressinsurrogate

Measurement of baroreceptor-mediated vasopressin release during upright tilt provides a clear marker to differentiate between pure autonomic failure and multiple system atrophy.

Abstract

To investigate whether activation of afferent and central baroreceptor pathways could differentiate between pure autonomic failure (PAF) and multiple system atrophy with autonomic failure (MSA), we determined the effect of upright tilt on circulating levels of vasopressin in patients with PAF and patients with MSA. We also studied 14 normal subjects, nine of whom developed acute hypotension due to vasovagal syncope. In patients with PAF and in normal subjects with vasovagal syncope, upright tilt induced marked hypotension and a pronounced increase in the plasma concentration of vasopressin (1.1 +/- 0.3 to 38.0 +/- 8.0 pmol/l in PAF and 1.0 +/- 0.2 to 27.4 +/- 7.2 pmol/l in vasovagal syncope, p less than 0.005 for both). In patients with MSA, upright tilt also elicited profound hypotension but circulating levels of vasopressin increased little (0.5 +/- 0.1 to 1.5 +/- 0.3 pmol/l, p less than 0.05). During upright tilt, the plasma concentration of norepinephrine significantly increased in normal subjects but did not increase in patients with autonomic failure. Our results indicate that afferent and central baroreceptor pathways involved in vasopressin release are normal in patients with PAF but are impaired in patients with MSA. Thus, measurement of baroreceptor-mediated vasopressin release appears to provide a clear marker to differentiate between patients with PAF and patients with MSA.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kaufmann et al. (1992) studied this question.

synapsesocial.com/papers/6a73dcddc553859489f1617ehttps://doi.org/10.1212/wnl.42.3.590
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1BLOOD PRESSURE AND VASOPRESSIN IN PROGRESSIVE AUTONOMIC FAILURE: RESPONSE TO POSTURAL STIMULATION, L-DOPA AND NALOXONE1983 · 41 citations
  2. 2Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure2003 · 235 citations
  3. 3Leg vasoconstriction during head-up tilt in patients with autonomic failure is not abolished2010 · 7 citations
  4. 4Autonomic control of vasovagal syncope1998 · 85 citations
  5. 5Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope2002 · 57 citations